Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Histologically-confirmed Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00509301
What this trial is testing

Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Recurrent Glioblastoma Multiforme
Peregrine Pharmaceuticals 12
Testing effectiveness (Phase 2)Study completedNCT02093598
What this trial is testing

POEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With Temsirolimus

Who this might be right for
Carcinoma, EndometrioidmTOR Protein
MedSIR 10
Not applicableEnded earlyNCT03563274
What this trial is testing

QuiremSpheres Observational Study

Who this might be right for
Liver, Cancer of, Non-Resectable
Terumo Europe N.V. 20
Testing effectiveness (Phase 2)Looking for participantsNCT07391813
What this trial is testing

SNB-101 for Treatment of Extensive Stage Small Cell Lung Cancer

Who this might be right for
Patient is Not Suitable for Complete Surgical Resection With a Cytologically or Histologically Confirmed Small Cell Lung Cancer(SCLC)
SN BioScience 55
Early research (Phase 1)Study completedNCT01320592
What this trial is testing

PD0332991/Paclitaxel in Advanced Breast Cancer

Who this might be right for
Breast Cancer
Abramson Cancer Center at Penn Medicine 28
Post-approval studies (Phase 4)Study completedNCT00220311
What this trial is testing

Confirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or Thrombocytopenia

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Genzyme, a Sanofi Company 10
Testing effectiveness (Phase 2)Study completedNCT02323646
What this trial is testing

Safety and Efficacy of Telapristone Acetate (Proellex®) Administered Vaginally for the Treatment of Uterine Fibroids

Who this might be right for
Uterine Fibroids
Repros Therapeutics Inc. 42
Not applicableNo Longer AvailableNCT05064306
What this trial is testing

131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults

Who this might be right for
Central Nervous System/Leptomeningeal Neoplasms
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00128635
What this trial is testing

Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Abramson Cancer Center at Penn Medicine 22
Large-scale testing (Phase 3)Study completedNCT03170050
What this trial is testing

Clinical Trial of YYD701-2 for Treatment of Nasolabial Folds

Who this might be right for
Wrinkle Severity Rating Scale(WSRS) Grade 3 (Moderate) or 4 (Severe) of Nasolabial Folds
Yooyoung Pharmaceutical Co., Ltd. 107
Early research (Phase 1)Study completedNCT00328458
What this trial is testing

EPO906 Plus Radiation Therapy for the Treatment of Cancer Patients

Who this might be right for
Central Nervous System NeoplasmsHead and Neck Neoplasms
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 39
Testing effectiveness (Phase 2)Looking for participantsNCT07725380
What this trial is testing

Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma

Who this might be right for
SarcomaOsteosarcoma
H. Lee Moffitt Cancer Center and Research Institute 74
Large-scale testing (Phase 3)Study completedNCT03063450
What this trial is testing

CheckpOiNt Blockade For Inhibition of Relapsed Mesothelioma

Who this might be right for
Mesothelioma
University of Southampton 332
Large-scale testing (Phase 3)Ended earlyNCT00412776
What this trial is testing

Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer

Who this might be right for
Carcinoma, Squamous Cell of Head and NeckCarcinoma, Squamous CellNeoplasms, Squamous Cell+3 more
Sesen Bio, Inc. 165
Testing effectiveness (Phase 2)Looking for participantsNCT07151040
What this trial is testing

Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors

Who this might be right for
Solid TumorColorectal Cancer (CRC)Squamous Cell Carcinoma of Head and Neck+3 more
One-carbon Therapeutics AB 43
Not applicableLooking for participantsNCT05652673
What this trial is testing

Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial

Who this might be right for
Melanoma Stage IVMelanoma Stage IIIImmunotherapy+1 more
Erasmus Medical Center 80
Not applicableStudy completedNCT00588198
What this trial is testing

Peripheral Blood and/or Bone Marrow, Including Detection of Occult Metastases, in Patients With Melanoma

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 754
Testing effectiveness (Phase 2)Study completedNCT02259582
What this trial is testing

Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Nonsquamous Nonsmall Cell Neoplasm of Lung
OncoMed Pharmaceuticals, Inc. 82
Early research (Phase 1)Study completedNCT05159518
What this trial is testing

PRT2527 in Participants With Advanced Solid Tumors

Who this might be right for
SarcomaCastrate Resistant Prostate CancerHormone Receptor Positive HER2 Negative Breast Cancer+2 more
Prelude Therapeutics Incorporated 30
Testing effectiveness (Phase 2)Ended earlyNCT00237900
What this trial is testing

Gefitinib in Combination With Chemoradiation in Resectable Gastric Cancer

Who this might be right for
Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC
AstraZeneca 34
Next Page